Akcea Therapeutics Inc (AKCA) Return on Investment ROI from the second quarter of 2020 to second quarter of 2019 and for the year 2020, average high and low, overall ranking from Jun 30 2020 to Jun 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Akcea Therapeutics Inc   (NASDAQ: AKCA)


Akcea Therapeutics Inc's ROI from its second quarter of 2020 to the second quarter of 2019 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Akcea Therapeutics Inc's ROI in the second quarter of 2020?
Akcea Therapeutics Inc recorded a cumulative net loss of $-42 million during 12 months ending in the second quarter of 2020, resulting in a negative return on investment (ROI) of -8.68%.

Within the Healthcare sector 246 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2020 from 0 to 3035.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter
Y / Y Investment Change TTM 40.82 % 42.38 % 67.3 % 57.86 % 65.3 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 493 524 557 340 384
Return On Investment (TTM) -8.68 % -6.49 % 9.67 % -31.8 % -42.47 %
AKCA's Overall Ranking # 3035 # 0 # 673 # 0 # 0
Seq. Investment Change TTM 6.05 % 7 % 19.5 % 3.85 % 7.23 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -42 -29 41 -112 -144

AKCA Company Profile >> Back to AKCA Roi Comparisons >> See Annual AKCA Return On Investment



Return On Investment AKCA's Ranking
Within: No.
Industry # 81
Sector # 247
Overall # 3035

Return On Investment Statistics
High Average Low
26.81 %
5.33 %
-8.68 %
(Mar 31 2019)   (Jun 30 2020)







Financial Statements
Akcea Therapeutics Inc's II. Quarter Investments $ 493 Millions AKCA's Balance sheet
Akcea Therapeutics Inc's II. Quarter Income $ -50 Millions Quarterly AKCA's Income Statement
AKCA's Income by Division See AKCA's Income by Division


AKCA Annual Return On Investment (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2015)
2017

Total Investments in Millions 557 282 -17 0 0
Y / Y Investment Growth 97.59 % - - - -
Net Income in Millions 41 -226 -61 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 7.32 % -80.07 % - - -


Annual Roi Comment
In the fiscal year 2019 ROI improved to 7.32 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AKCA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AKCA's Competitors
Subscribers only: Roi for Akcea Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for AKCA's Customers

Other Ratios
AKCA's Roa AKCA's Inventory Turnover Ratio AKCA's Growth Rates AKCA's Dividend Statistics
AKCA's Profitability Ratios AKCA's Asset Turnover Ratio AKCA's Dividend Growth
AKCA's Roe AKCA's Valuation Ratios AKCA's Financial Strength Ratios AKCA's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2020, within Healthcare Sector ROI

Date modified: 2026-08-29T17:40:54+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.